Prior studies have shown that TGF-β can modify tumor activity by inhibiting host tumor immune surveillance and directly regulating oncogenic metabolism in EMT, cellular invasion and metastasis (Huber-Ruano et al., 2017; Lee et al., 2017; Ungefroren, 2019). The gene discussed is TGFB1; the disease is neoplasm.